Basic Information
| LncRNA/CircRNA Name | DBH-AS1 |
| Synonyms | NA |
| Region | GRCh38_9:133654586-133657313 |
| Ensemble | ENSG00000225756 |
| Refseq | NR_002783 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | osteosarcoma tissue and cell lines |
| Expression Pattern | up-regulated |
| Function Description | We observed that DBH-AS1 was distinctly overexpressed in osteosarcoma tissue and cells, and associated with lymph node status and metastasis status. |
| Pubmed ID | 30840262 |
| Year | 2019 |
| Title | Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. |
External Links
| Links for DBH-AS1 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |